Full Sanity Earnout Amendment Agreements Filed, Including Related-Party Details
OGI sits 37% above its 52-week low of $0.853 on light trading volume (0.3× avg).
Summary
Full legal agreements for the amended Sanity Group earnout were filed, disclosing a fixed €102 million earnout (less deductions), related-party transaction values, and a €12 million working capital loan.
Key Events · M&A and Partnerships · OGI
-
Fixed Earnout Set at €102M
The amended earnout is fixed at €102,000,000, reduced by €2,560,750.43 and €3,509,598.76 in deductions, replacing the original performance-based earnout of up to €113.8 million.
-
Payment Structure and Timeline
Earnout consists of €20 million in cash and approximately €76 million in shares, payable as of April 1, 2027, with settlement no later than May 1, 2027, subject to a C$3.00 floor and C$4.00 cap on share pricing.
-
Related-Party Transaction Details
BT DE Investments Inc. (BAT subsidiary) holds earnout consideration of C$16,680,531.41; Finn Age Hänsel holds C$18,792,182.00 in earnout plus C$533,221.50 in equity awards; Adrian Frenzel holds C$1,823,141.13 in earnout plus C$533,211.50 in equity awards.
-
Working Capital Loan
The amended agreement includes a shareholder loan of €12,000,000 (up to €15,000,000) to finance working capital during the earnout period, repayable on the earnout date.
Analysis · OGI · Life Sciences
Investors now have clarity on the remaining consideration and the related-party nature of the transaction, which involves BAT and former Sanity executives. The complete First and Second Amendment Agreements to the Sanity Group share purchase agreement were filed, providing the full legal text and detailed related-party transaction values. A fixed earnout of €102 million (less deductions) replaces the original performance-based earnout, with €20 million in cash and approximately €76 million in shares payable by May 1, 2027. The filing also discloses a €12 million shareholder loan for working capital during the earnout period.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 30.2% of the 2009 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.11%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, OGI was trading at $1.17 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $170.6M. The 52-week trading range was $0.85 to $2.24. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.